Suppr超能文献

涎腺细胞病理学报告米兰系统的实用性:一项回顾性 5 年研究。

Utility of the Milan system for reporting salivary gland cytopathology: A retrospective 5 years study.

机构信息

Department of Pathology, Seth Gordhandas Sunderdas Medical College and KEM Hospital, Mumbai, India.

Department of Pathology, Lokmanya Tilak Municipal Medical College and General Hospital, Mumbai, India.

出版信息

Diagn Cytopathol. 2021 Apr;49(4):500-508. doi: 10.1002/dc.24697. Epub 2021 Jan 14.

Abstract

BACKGROUND

Fine-needle aspiration cytology (FNAC) is an established technique for preoperative diagnosis of salivary gland lesions; however, lack of a uniform reporting system has been a handicap. The main aims of this study were to evaluate the utility of the - "The Milan System for Reporting Salivary Gland Cytopathology" (MSRSGC) and ascertain the risk of malignancy (ROM) for each category.

METHODS

All salivary gland FNACs over 5 years (January 2014-December 2018) were reviewed and assigned a diagnostic category from the MSRSGC. Clinical data were taken from Cytology records. Cytodiagnosis was correlated with histopathology wherever available and ROM was calculated.

RESULTS

A total of 120 salivary gland FNACs were studied. Age ranged between 5 and 85 years, male:female ratio was 2:1 and parotid was the commonest gland aspirated. Cases were reclassified as I non-diagnostic (2.5%), II non-neoplastic (15%), III atypia of uncertain significance-AUS (1.7%), IV A neoplasm benign (50%), IV B neoplasm of uncertain malignant potential (12.5%), V suspicious for malignancy (5%), and VI malignant (13.3%). Follow-up was available in 70 (58.3%) cases. The sensitivity, specificity, negative predictive value, and positive predictive value were 92.3%, 100%, 100%, and 98.27% respectively. ROM was non-neoplastic (0%), AUS (50%), neoplasm benign (0%), neoplasm of uncertain malignant potential (28.6%), suspicious for malignancy (100%), and malignant (100%).

CONCLUSION

Salivary gland FNAC is a reliable diagnostic tool and the "Milan system" will further increase FNA reliability, help risk stratification, and improve patient care.

摘要

背景

细针吸取细胞学(FNAC)是术前诊断唾液腺病变的成熟技术;然而,缺乏统一的报告系统一直是一个障碍。本研究的主要目的是评估“米兰唾液腺细胞病理学报告系统”(MSRSGC)的实用性,并确定每个类别中的恶性肿瘤风险(ROM)。

方法

回顾了过去 5 年(2014 年 1 月至 2018 年 12 月)的所有唾液腺 FNAC,并根据 MSRSGC 分配了诊断类别。临床数据取自细胞学记录。在有条件的情况下,将细胞学诊断与组织病理学相关联,并计算 ROM。

结果

共研究了 120 例唾液腺 FNAC。年龄在 5 至 85 岁之间,男女比例为 2:1,最常见的是腮腺抽吸。病例被重新分类为 I 未诊断(2.5%)、II 非肿瘤性(15%)、III 意义不明的非典型性-AUS(1.7%)、IV A 良性肿瘤(50%)、IV B 恶性潜能不明的肿瘤(12.5%)、V 疑似恶性肿瘤(5%)和 VI 恶性肿瘤(13.3%)。70 例(58.3%)有随访。敏感性、特异性、阴性预测值和阳性预测值分别为 92.3%、100%、100%和 98.27%。ROM 为非肿瘤性(0%)、AUS(50%)、良性肿瘤(0%)、恶性潜能不明的肿瘤(28.6%)、疑似恶性肿瘤(100%)和恶性肿瘤(100%)。

结论

唾液腺 FNAC 是一种可靠的诊断工具,“米兰系统”将进一步提高 FNA 的可靠性,帮助风险分层,改善患者护理。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验